跳至主要内容
临床试验/ISRCTN87407792
ISRCTN87407792已完成未知

SeconDary Stroke PreVEntion ThRough Pathway ManagemenT (DiVERT Stroke)

Medtronic (United States)0 个研究点目标入组 6,536 人开始时间: 2021年3月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
6,536

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • Current inclusion criteria as of 01/09/2022:
  • US Inclusion Criteria:
  • 1. Patients with a cryptogenic stroke or large artery atherosclerosis or small vessel occlusion hospitalization between 2017 – 2019
  • 2. Age =18 years
  • UK Inclusion Criteria:
  • 1. Patients with a cryptogenic stroke or large artery atherosclerosis or small vessel occlusion hospitalization between 2019-2020. If ischemic stroke sub-type classification proves to be difficult (i.e., small sample size), patients with an ischemic stroke from 2017-2019 will be included.
  • 2. Age =18 years
  • Previous inclusion criteria from 20/05/2021 to 01/09/2022:
  • 1. Patients with a cryptogenic stroke or large artery atherosclerosis or small vessel occlusion
  • hospitalization between 2017 – 2019
  • 2. Age =18 years
  • Previous inclusion criteria:
  • 1. Patients with a cryptogenic stroke hospitalization defined by ICD-10 I63.9 between 2017 – 2019
  • 2. Age =18 years

排除标准

  • Current exclusion criteria as of 20/05/2021:
  • Does not meet inclusion criteria
  • Previous exclusion criteria:
  • 1. Any history of the following through index stroke:
  • 1.1. Lacunar stroke
  • 1.2. Large artery atherosclerosis
  • 1.3. Diagnosis of AF or atrial flutter
  • 1.4. Ablation for AF or atrial flutter
  • 1.5. OAC use
  • 1.6. Methamphetamines drug use
  • 1.7. Mechanical heart valves
  • 1.8. Rheumatic heart disease
  • 1.9. Mitral stenosis
  • 1.10. Ischemic cardiomyopathy
  • 1.11. Dilated cardiomyopathy
  • 1.12. ST-elevation MI
  • 1.13. Vasculitis
  • 1.14. End stage renal disease
  • 1.15. ICM implant prior to index event
  • 2. VT Ablation within 30 days of index event
  • 3. Non-AF left atrial or ventricular ablation within 30 days of index event
  • 4. Any of the following within 30 days pre to 90 days post index stroke:
  • 4.1. Carotid artery stenting
  • 4.2. Carotid endarterectomy
  • 4.3. Carotid artery stenosis or occlusion
  • 4.4. ASD closure device insertion

研究者

发起方
Medtronic (United States)

相似试验